SpotitEarly has formed a strategic partnership with Fox Chase Cancer [...]

Patients in Scotland living with extensive-stage small cell lung cancer [...]

Syncromune has appointed Stephen Dale as chief medical officer, strengthening [...]

Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

Merck has announced that the US Food and Drug Administration [...]

Bio‑Sourcing and Zerion Pharma have joined forces to develop the [...]

Shilpa Medicare Limited is targeting US approval for its Ondansetron [...]

CERo Therapeutics has reported early clinical findings from its ongoing [...]

Breast cancer remained the world’s most studied disease for the [...]

Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]